Wegovy 0.25 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7ZJH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,074
Award facts
- Contract value 100% obligated
- $41,074.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $41,074.45 to AmerisourceBergen Drug Corp for the supply of Wegovy (semaglutide) 0.25 mg/0.5 mL pen injections on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026 that enables comprehensive pharmaceutical and medical supply support for military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor specializing in brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's extensive portfolio of competitively awarded DLA contracts demonstrates its capability to fulfill diverse federal healthcare requirements, supporting customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Wegovy, a GLP-1 receptor agonist used in diabetes and weight management treatment, reflects the company's role in supplying specialized pharmaceutical products to support military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F7ZJH?
SPE2DR26F7ZJH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F7ZJH worth?
The government has obligated $41,074 on SPE2DR26F7ZJH.
Is contract SPE2DR26F7ZJH an order under another contract?
Yes. SPE2DR26F7ZJH is a delivery order under SPE2DR25D7066, an indefinite delivery contract.
Was contract SPE2DR26F7ZJH competed?
The extent of competition for SPE2DR26F7ZJH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award